Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Net Cash Flow (2019 - 2025)

Strata Critical Medical (SRTA) has disclosed Net Cash Flow for 7 consecutive years, with $8.2 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 597.94% to $8.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.9 million through Dec 2025, up 228.3% year-over-year, with the annual reading at $11.9 million for FY2025, 228.3% up from the prior year.
  • Net Cash Flow for Q4 2025 was $8.2 million at Strata Critical Medical, up from -$36.7 million in the prior quarter.
  • The five-year high for Net Cash Flow was $185.0 million in Q2 2022, with the low at -$336.2 million in Q3 2021.
  • Average Net Cash Flow over 5 years is -$8.3 million, with a median of -$1.6 million recorded in 2024.
  • Peak annual rise in Net Cash Flow hit 7144.04% in 2021, while the deepest fall reached 82704.02% in 2021.
  • Over 5 years, Net Cash Flow stood at -$4.3 million in 2021, then plummeted by 98.76% to -$8.6 million in 2022, then fell by 7.24% to -$9.3 million in 2023, then surged by 82.2% to -$1.6 million in 2024, then skyrocketed by 597.94% to $8.2 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $8.2 million, -$36.7 million, and $24.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.